Xingai Ju

Xingai Ju


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2025 in Frontiers in Public Health
Verified
Journal Article
Open access
PDF file
TRTing Ruan
Ting Ruan
XSXinran Shao
Xinran Shao
YSYihan Sun
Yihan Sun
XJXingai Ju
Xingai Ju
JCJianchun Cui
Jianchun Cui
Objective: This study assessed the accuracy, quality, and readability of responses from three leading AI chatbots—ChatGPT-3.5, DeepSeek-V3, and Google Gemini-2.5—on the diagnosis, treatment, and long-term risks of adult hypothyroidism, comparing their outputs with current clinical guidelines. Methods: Two thyroid specialists developed 27 questions based on the Guideline for the Diagnosis and Management of Hypothyroidism in Adults (2017 edition), covering three categories: diagnosis, treatment, and long-term health risks. Responses from each AI model were independently evaluated by two reviewers. Accuracy was rated using a six-point Likert scale, quality using the DISCERN tool and the five-point Likert scale, and readability was assessed by the Flesch Reading Ease (FRE), Flesch–Kincaid Grade Level (FKGL), Gunning Fog Index (GFI),and Simple Measure of Gobbledygook(SMOG). Results: All three AI models demonstrated excellent performance in accuracy (mean score > 4.5) and quality (high-quality rate > 94%). According to the DISCERN tool, no significant difference was observed in the overall information quality among the models. However, Gemini-2.5 generated responses of significantly lower quality for treatment-related questions than for diagnostic inquiries. The content generated by all models was relatively difficult to comprehend (low FRE scores and high FKGL/GFI scores), generally requiring a college-level or higher education for adequate understanding. Conclusion: All three AI chatbots were capable of producing highly accurate and high-quality medical information regarding hypothyroidism, with their responses showing strong consistency with clinical guidelines. This underscores the substantial potential of AI in supporting medical information delivery. However, the consistently high reading difficulty of their outputs may limit their practical utility in patient education. Future research should focus on improving the readability and patient-friendliness of AI outputs—through prompt engineering and multi-round dialogue optimization—while maintaining professional accuracy, to enable broader application of AI in health education.

9 July 2026 in International Journal of Medical Informatics
Verified
Journal Article
Closed access
QLQiushi Li
Qiushi Li
YSYihan Sun
Yihan Sun
XJXingai Ju
Xingai Ju
JCJianchun Cui
Jianchun Cui

21 July 2026 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
WZWanli Zheng
Wanli Zheng
YTYibei Tang
Yibei Tang
XCXuanyu Chen
Xuanyu Chen
WYWang Ye
Wang Ye
JYJingyao Yu
Jingyao Yu
XJXingai Ju
Xingai Ju
Objective: To identify factors associated with successful levothyroxine (L-T4) withdrawal in patients with primary hypothyroidism and to develop a clinical prediction model. Methods: We retrospectively included patients with primary hypothyroidism who received L-T4 treatment at our hospital between January 2016 and October 2024 and had a documented withdrawal attempt with follow-up records. Baseline patient data were collected, including sociodemographic characteristics (age, sex, body mass index [BMI], family history of thyroid disease), medication-related indices (L-T4 dosage and treatment duration), clinical classification (subclinical vs. overt hypothyroidism), and laboratory and ultrasound imaging parameters (TSH, FT3, FT4, TPOAb, TgAb, heterogeneous echotexture, and hypoechogenicity). Successful withdrawal was defined as maintenance of euthyroidism for 12 months after stopping L-T4; otherwise, withdrawal was considered unsuccessful. Candidate predictors were screened using univariate logistic regression and entered into multivariable logistic regression to identify independent predictors and construct a nomogram. Discriminative ability was assessed using the area under the receiver operating characteristic curve (AUC). Calibration and internal validation were evaluated using the Hosmer-Lemeshow test and bootstrap resampling (1,000 iterations). Results: A total of 110 patients were included, of whom 39 (35.5%) achieved successful withdrawal and 71 (64.5%) did not. In multivariable analysis, younger age (OR = 0.901, 95% CI: 0.852–0.953, P < 0.001) and subclinical hypothyroidism (OR = 4.879, 95% CI: 1.343–17.723, P = 0.016) were associated with a higher likelihood of successful withdrawal. In contrast, TPOAb positivity (OR = 0.150, 95% CI: 0.040–0.556, P = 0.005) and heterogeneous thyroid echotexture on ultrasound (OR = 0.155, 95% CI: 0.032–0.751, P = 0.021) were associated with a lower likelihood of success. The model showed excellent discrimination (AUC = 0.899, 95% CI: 0.840–0.957, P < 0.001). At the optimal cutoff value of 0.292, sensitivity was 87.2% and specificity was 80.3%. Model fit was good (Hosmer-Lemeshow χ² = 5.448, P = 0.709), and bootstrap validation demonstrated good calibration (mean absolute error = 0.029). Conclusion: Younger age, subclinical hypothyroidism, negative TPOAb, and homogeneous thyroid echotexture were associated with a higher likelihood of successful L-T4 withdrawal. The nomogram model may facilitate pre-withdrawal risk stratification and individualized follow-up planning, supporting quantitative decision-making in clinical practice.

1 May 2026 in Gland Surgery
Verified
Journal Article
Open access
PDF file
QLQiushi Li
Qiushi Li
XSXinran Shao
Xinran Shao
DBDongning Bi
Dongning Bi
YSYihan Sun
Yihan Sun
JYJingyao Yu
Jingyao Yu
JCJianchun Cui
Jianchun Cui
Background: Surgical decision-making for intraductal breast lesions has traditionally relied on physician expertise and imaging characteristics, lacking a comprehensive evaluation framework that integrates oncological efficacy, perioperative safety, and patient subjective experience. This study aimed to systematically synthesise the latest evidence and incorporate patient-reported outcomes (PROs) to construct a three-dimensional evaluation model, thereby providing an evidence base for the individualised selection between vacuum-assisted excision (VAE) and open surgery. Methods: A systematic comparison and descriptive analysis were performed across three dimensions: oncological efficacy, perioperative safety, and PROs. A total of 26 studies were included. Results: Meta-analysis revealed no significant difference in residual lesion rates between the VAE and open surgery groups [risk ratios (RR) =1.02; 95% confidence interval (CI): 0.29–3.57; P=0.97]. Notably, the VAE group demonstrated a 59% significant reduction in recurrence rates (RR =0.43; 95% CI: 0.21–0.86; P=0.02). Due to the lack of direct comparative data, malignancy detection rates were presented descriptively without statistical pooling, and no inferences regarding diagnostic superiority were drawn. Regarding perioperative safety, VAE was associated with a significantly shorter operative time [mean difference (MD) =−14.38 min; 95% CI: −17.09 to −11.67; P<0.01] and reduced intraoperative blood loss (MD =−9.10 mL; 95% CI: −11.29 to −6.92; P<0.01). Furthermore, VAE significantly lowered the risks of skin ecchymosis (RR =0.43; 95% CI: 0.20–0.95; P=0.04), wound infection (RR =0.31; 95% CI: 0.14–0.69; P=0.004), and breast deformity (RR =0.19; 95% CI: 0.05–0.74; P=0.02). For PROs, patients in the VAE group reported significantly higher cosmetic satisfaction (RR =1.34; 95% CI: 1.15–1.56; P<0.001) and lower postoperative pain scores (MD =−1.61; 95% CI: −2.68 to −0.54; P=0.003). Conclusions: VAE offers clear benefits such as being minimally invasive, supporting postoperative recovery, and improving cosmetic satisfaction, making it a preferred method for radiologically localised lesions. However, current evidence is insufficient to confirm VAE as a definitive treatment for malignant or high-risk intraductal conditions. Open surgery remains essential to ensure oncological safety through thorough margin assessment and accurate detection of malignancy; the potential clinical consequences of missing malignancy greatly outweigh minor cosmetic outcomes. Future treatment options should be guided by personalised decision-making that considers lesion characteristics and patient preferences.

11 August 2026 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
JZJipeng Zheng
Jipeng Zheng
YTYibei Tang
Yibei Tang
YGYang Gao
Yang Gao
YSYihan Sun
Yihan Sun
GLGang Li
Gang Li
JCJianchun Cui
Jianchun Cui
Objective: To systematically review the literature on ductoscopy-related operative failures, establish a classification system for “Complex Ductoscopy Operating Procedure (CDOP)”, and propose standardized clinical response strategies. Methods: A comprehensive search of PubMed, Embase, Web of Science, Scopus, and Cochrane Library was conducted for publications from January 1991 to July 2026. Causes of ductoscopy failure were extracted, categorized, and quantitatively summarized. The methodological quality of included studies was evaluated. Based on literature evidence and accumulated clinical experience, a standard CDOP-PFN (Passing, Finding, Non-discharge) classification system and stepwise clinical management framework were developed. Results: From 25 included studies (2,853 procedures), meta-analysis showed a pooled failure rate of 10.0% (95%CI: 6.8%–13.7%; 95% PI: 0.0%–31.4%) with high heterogeneity (I² = 87.1%). Primary causes were ductal perforation (22.5%), ductal stenosis (21.9%), and nipple deformity/retraction (12.1%). Failures were stratified into three major types (PFN): (i) presence of nipple discharge with inability to access the ductal system via ductoscopy (type P, passing); (ii) bloody discharge with failure to identify intraductal lesions (type F, finding); and (iii) absence of spontaneous discharge but ultrasonographic evidence of ductal dilatation and intraductal lesions (type N, non-discharge). For each type, a tiered strategy was formulated, incorporating pre-procedural evaluation, duct entry optimization, image-guided localization, troubleshooting, and surgical approaches when needed. Conclusion: The proposed CDOP-PFN classification and management framework standardizes the recognition and handling of complex ductoscopy operating scenarios. These strategies may reduce dependency on individual operator experience, improve procedural standardization and safety, enhance diagnostic yield for intraductal lesions, and advance minimally invasive breast disease management.

19 June 2026 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
YSYunzhi Shen
Yunzhi Shen
XSXinran Shao
Xinran Shao
SMShuai Ma
Shuai Ma
YSYihan Sun
Yihan Sun
JLJinrui Liu
Jinrui Liu
DZDONGXIAO ZHANG
DONGXIAO ZHANG
Objective: To systematically summarize study-level factors associated with postoperative hematoma after ultrasound-guided vacuum-assisted breast lesion excision(VAE) using a vacuum-assisted breast biopsy (VABB) system, and to organize the available evidence according to a novel T-P-B framework comprising tumor-related, position-related, and breast- or peri-procedural management-related factors. Methods: A systematic search was conducted in PubMed, China National Knowledge Infrastructure, Wan fang Data, VIP Database, and Elsevier Clinical Key for studies published between January 1995 and October 2025. Observational studies investigating risk factors for hematoma after VAE using a VABB system were included. Study-derived exposure categories and cutoff values were retained. Study quality was assessed using the Newcastle–Ottawa Scale (NOS). Meta-analysis was performed using R (version 4.5.1). Effect sizes were expressed as odds ratios (ORs) with corresponding 95% confidence intervals (CIs) and were pooled using the inverse-variance method. Heterogeneity was assessed using the I² statistic, and a random-effects model was applied. Sensitivity analysis was conducted by sequentially excluding individual studies (leave-one-out analysis). A two-sided p value < 0.05 was considered statistically significant. Results: A total of 11 retrospective studies involving 3,516 patients who underwent VAE using a VABB system were included, among whom 444 cases of postoperative hematoma were reported. Five study-level factors were identified. Meta-analysis demonstrated that, within the T dimension, tumor numbers (OR = 4.21, 95% CI = 2.59–6.85), numbers of cutting passes(OR=3.87,95%CI=2.16-6.95)were significantly associated with hematoma formation. Within the P dimension, non-moderate tumor depth, including superficial or deep tumor, was associated with postoperative hematoma (OR = 4.39, 95% CI: 1.21–15.92), as was higher vascularity grade (OR = 2.60, 95% CI: 1.42–4.76). Within the B dimension, postoperative compression duration <48 h was associated with hematoma formation (OR = 4.34, 95% CI: 2.53–7.45). Sensitivity analyses showed generally consistent directions of association. Conclusions: This systematic review and meta-analysis identified five study-level factors associated with postoperative hematoma after VAE using a VABB system: tumor numbers, a higher number of cutting passes, non-moderate tumor depth including superficial or deep tumor, higher vascularity grade, and postoperative compression duration <48 h. The T-P-B framework may provide a clinically interpretable structure for organizing these factors and informing perioperative risk assessment.